COVID-19 Vaccine Studies: Free E-Book

UPDATED TO INCLUDE (9/16/21): Gazit, S. Schlezinger, R., Perez, G., Lotan, R., Peretz, A.,, Ben-Tov, A., Cohen, D., Muhsen, G.C., & Patalon, T. (2021). Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: Reinfections versus breakthrough infections. medRxiv (preprint).

Blackburn, J., Yiannoutsos, C. T., Carroll, A. E., Halverson, P. K., & Menachemi, N. (2020). Infection fatality ratios for COVID-19 among noninstitutionalized persons 12 and older: results of a random-sample prevalence study. Annals of Internal Medicine, 174(1): 135-36.

Brown, C.M., Vostok, J., Johnson, H., ... Laney, S. (6 August 2021). Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings - Barnstable County, Massachusetts, July 2021. MMWR Morbidity and Mortality Weekly Report, 2021(70): 1059-62. 

Cardozo, T. & Veazey, R. (2021). Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease. International Journal of Clinical Practice, 75(3): e13795.

CDC. (2021). COVID Data Tracker.

CDC. (2021). Demographic trends of COVID-19 cases and deaths in the US reported to CDC.

CDC. (2021). Disease burden of influenza.

CDC. (2020). Estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States: 2018–2019 influenza season.

Driver, G. (14 Sept. 2020). Lockdown critic says COVID-19 is only slightly worse than the flu. AAP.

Garske, T., Legrand, J., Donnelly, C. A., Ward, H., Cauchemez, S., Fraser, C., Ferguson, N. M., & Ghani, A. C. (2009). Assessing the severity of the novel influenza A/H1N1 pandemic. British Medical Journal (Clinical Research Ed.), 339: b2840.

Goldberg, Y., Mandel, M., Woodbridge, Y., Fluss, R., Novikov, I., Yaari, R., Ziv, A., Freedman, L., & Huppert, A. (2021). Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel. medRxiv (preprint).

Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., Munro, K., Wallace, S., Kirwan, P. D., Shrotri, M., Vusirikala, A., Rokadiya, S., Kall, M., Zambon, M., Ramsay, M., Brooks, T., … SIREN Study Group. (2021). SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet, 397(10283): 1459-69.

Hanrath, A. T., Payne, B., & Duncan, C. (2021). Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection. The Journal of Infection, 82(4), e29-e30.

Ioannidis, J. (2021). Infection fatality rate of Covid-19 inferred from seroprevalence data. Bulletin of the World Health Organization, 99(1), 19-33F.

Ioannidis, J. (2021). Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations. European Journal of Clinical Investigation, 51(5), e13554.

Kottow M. (2004). The battering of informed consent. Journal of Medical Ethics, 30(6), 565-69.

Lumley, S. F., O'Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., Peck, L. J., Ritter, T. G., de Toledo, Z., Warren, L., Axten, D., Cornall, R. J., Jones, E. Y., Stuart, D. I., Screaton, G., Ebner, D., … Oxford University Hospitals Staff Testing Group (2021). Antibody status and incidence of SARS-CoV-2 infection in health care workers. The New England Journal of Medicine, 384(6): 533-40.

Moro, P.L., Arana, J., Cano, M., Lewis, P. & Shimabukuro, T.T. (2015). Deaths reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013. Clinical Infectious Diseases, 61(6): 980-87.

Pilz, S., Chakeri, A., Ioannidis, J. P., Richter, L., Theiler-Schwetz, V., Trummer, C., Krause, R., & Allerberger, F. (2021). SARS-CoV-2 re-infection risk in Austria. European Journal of Clinical investigation, 51(4): e13520.

Sheehan, M. M., Reddy, A. J., & Rothberg, M. B. (2021). Reinfection rates among patients who previously tested positive for COVID-19: A retrospective cohort study. Clinical Infectious Diseases: An official publication of the Infectious Diseases Society of America: ciab234. 

Shrestha, N.K., Burke, P.C., Nowacki, A.S., Terpeluk, P. & Gordon, S.M. (2021). Necessity of COVID-19 vaccination in previously infected individuals. medRxiv (preprint).

Vaccine Adverse Events Reporting System

World Health Organization. (17 March 2020). Coronavirus disease (COVID-19): Similarities and differences with influenza.